RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 125 filers reported holding RELAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,244 | -44.7% | 1,213,725 | -27.5% | 0.47% | -71.2% |
| Q1 2023 | $27,567 | +26.8% | 1,673,743 | +15.1% | 1.64% | +35.0% |
| Q4 2022 | $21,733 | -99.9% | 1,454,716 | 0.0% | 1.21% | -12.7% |
| Q3 2022 | $32,542,000 | +177.5% | 1,454,716 | +107.8% | 1.39% | +121.9% |
| Q2 2022 | $11,725,000 | -44.0% | 700,000 | 0.0% | 0.63% | -28.6% |
| Q1 2022 | $20,951,000 | -9.0% | 700,000 | -6.7% | 0.88% | +40.3% |
| Q4 2021 | $23,033,000 | +82.6% | 750,000 | +87.5% | 0.62% | +121.6% |
| Q3 2021 | $12,612,000 | -13.8% | 400,000 | 0.0% | 0.28% | -5.1% |
| Q2 2021 | $14,636,000 | +5.8% | 400,000 | 0.0% | 0.30% | +21.7% |
| Q1 2021 | $13,828,000 | -16.8% | 400,000 | 0.0% | 0.24% | -31.7% |
| Q4 2020 | $16,624,000 | -2.4% | 400,000 | 0.0% | 0.36% | -13.8% |
| Q3 2020 | $17,036,000 | – | 400,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |